Lin YS - Search Results

1

In vitro metabolism of cyclosporine A by human kidney CYP3A5.

Dai Y, Iwanaga K, Lin YS, Hebert MF, Davis CL, Huang W, Kharasch ED, Thummel KE. Dai Y, et al. Among authors: lin ys. Biochem Pharmacol. 2004 Nov 1;68(9):1889-902. doi: 10.1016/j.bcp.2004.07.012. Biochem Pharmacol. 2004. PMID: 15450954

2

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.

Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E. Kuehl P, et al. Nat Genet. 2001 Apr;27(4):383-91. doi: 10.1038/86882. Nat Genet. 2001. PMID: 11279519

3

Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.

Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Thummel KE, et al. Mol Pharmacol. 2001 Dec;60(6):1399-406. doi: 10.1124/mol.60.6.1399. Mol Pharmacol. 2001. PMID: 11723248

4

In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration.

Lin YS, Lockwood GF, Graham MA, Brian WR, Loi CM, Dobrinska MR, Shen DD, Watkins PB, Wilkinson GR, Kharasch ED, Thummel KE. Lin YS, et al. Pharmacogenetics. 2001 Dec;11(9):781-91. doi: 10.1097/00008571-200112000-00006. Pharmacogenetics. 2001. PMID: 11740342

5

Common allelic variants of cytochrome P4503A4 and their prevalence in different populations.

Lamba JK, Lin YS, Thummel K, Daly A, Watkins PB, Strom S, Zhang J, Schuetz EG. Lamba JK, et al. Among authors: lin ys. Pharmacogenetics. 2002 Mar;12(2):121-32. doi: 10.1097/00008571-200203000-00006. Pharmacogenetics. 2002. PMID: 11875366

6

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.

Lin YS, Dowling AL, Quigley SD, Farin FM, Zhang J, Lamba J, Schuetz EG, Thummel KE. Lin YS, et al. Mol Pharmacol. 2002 Jul;62(1):162-72. doi: 10.1124/mol.62.1.162. Mol Pharmacol. 2002. PMID: 12065767

7

Genetic contribution to variable human CYP3A-mediated metabolism.

Lamba JK, Lin YS, Schuetz EG, Thummel KE. Lamba JK, et al. Among authors: lin ys. Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94. doi: 10.1016/s0169-409x(02)00066-2. Adv Drug Deliv Rev. 2002. PMID: 12406645 Review.

8

CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians.

Rettie AE, Tai G, Veenstra DL, Farin FM, Srinouanprachan S, Lin YS, Thummel KE, Hines RN. Rettie AE, et al. Among authors: lin ys. Blood. 2003 Apr 1;101(7):2896-7. doi: 10.1182/blood-2002-11-3452. Blood. 2003. PMID: 12642346 Free article. No abstract available.

9

CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.

Givens RC, Lin YS, Dowling AL, Thummel KE, Lamba JK, Schuetz EG, Stewart PW, Watkins PB. Givens RC, et al. Among authors: lin ys. J Appl Physiol (1985). 2003 Sep;95(3):1297-300. doi: 10.1152/japplphysiol.00322.2003. Epub 2003 May 16. J Appl Physiol (1985). 2003. PMID: 12754175 Free article. Clinical Trial.

10

Transiently altered acetaminophen metabolism after liver transplantation.

Park JM, Lin YS, Calamia JC, Thummel KE, Slattery JT, Kalhorn TF, Carithers RL Jr, Levy AE, Marsh CL, Hebert MF. Park JM, et al. Among authors: lin ys. Clin Pharmacol Ther. 2003 Jun;73(6):545-53. doi: 10.1016/S0009-9236(03)00062-6. Clin Pharmacol Ther. 2003. PMID: 12811364 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,215 results

Search Page